Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial The Times of India 2d The Times of India 2d
Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer News-Medical.Net 1d News-Medical.Net 1d
Study identifies blood proteins associated with aggressive prostate cancer risk News-Medical.Net 5d News-Medical.Net 5d
A promising development in prostate cancer care: can immunotherapy help? The Hindu 6d The Hindu 6d Article paywall
Lower Metastasis Risk in Very High-Risk Prostate Cancer With Intensified Treatment Medpage Today 15:38
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer substudy supports reduced risk of metastasis and death Newswise (Press Release) 15:04
Concert raises nearly £12,000 for cancer research Mid and South Essex NHS Foundation Trust (Press Release) 14:51
Study reveals a broad shift away from overtreatment of low-risk prostate cancer News-Medical.Net 14:03
Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer News-Medical.Net 17:11 Sun, 25 Oct
Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial The Times of India 09:29 Sat, 24 Oct